Shares in Teva Pharmaceuticals (NYSE:TEVA) climbed 12% this morning after the company announced it plans to cut more than a quarter of its global workforce, suspend its dividend and shut down research facilities and factories.
The drug-maker, which appointed a new CEO and management team this year, is looking to restructure and pay down debt.
Get the full story at our sister site, Drug Delivery Business News.